STOCK TITAN

Linde (LIN) CFO granted new stock options and units, settles prior awards

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Linde plc Chief Financial Officer Matthew J. White reported equity compensation grants and related share settlements. On March 9, 2026, he received performance share units covering 8,136 ordinary shares tied to return on capital and 2,870 shares tied to relative total shareholder return, plus 3,098 restricted stock units and stock options over 25,259 ordinary shares at an exercise price of 483.6200 per share expiring in 2036.

The filing also shows exercises of performance share units and restricted stock units into 13,876 ordinary shares, with 6,431 shares withheld at 484.7400 per share to cover tax obligations. Following these transactions, White directly holds 83,094.804 ordinary shares and also has indirect holdings of 3,096.221 ordinary shares through a 401(k) plan, along with multiple unexercised option and unit awards that vest over future years.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
White Matthew J

(Last) (First) (Middle)
C/O LINDE PLC
FORGE, 43 CHURCH STREET WEST

(Street)
WOKING SURREY X0 GU216HT

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
LINDE PLC [ LIN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
03/09/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Ordinary Shares 03/09/2026 M 8,136(1) A $0 83,785.804 D
Ordinary Shares 03/09/2026 F 3,771(2) D $484.74 80,014.804 D
Ordinary Shares 03/09/2026 M 2,870(1) A $0 82,884.804 D
Ordinary Shares 03/09/2026 F 1,330(2) D $484.74 81,554.804 D
Ordinary Shares 03/09/2026 M 2,870(3) A $0 84,424.804 D
Ordinary Shares 03/09/2026 F 1,330(2) D $484.74 83,094.804 D
Ordinary Shares 3,096.221 I 401(k)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Performance Share Units (ROC) (4) 03/09/2026 A 8,136 (5) (5) Ordinary Shares 8,136 $0 8,136 D
Performance Share Units (ROC) (4) 03/09/2026 M 8,136 (5) (5) Ordinary Shares 8,136 $0 0 D
Performance Share Units (RTSR) (4) 03/09/2026 A 2,870 (6) (6) Ordinary Shares 2,870 $0 2,870 D
Performance Share Units (RTSR) (4) 03/09/2026 M 2,870 (6) (6) Ordinary Shares 2,870 $0 0 D
Restricted Stock Units (4) 03/09/2026 A 3,098 (7) (7) Ordinary Shares 3,098 $0 3,098 D
Restricted Stock Units (4) (8) (8) Ordinary Shares 2,728 2,728 D
Restricted Stock Units (4) (9) (9) Ordinary Shares 2,625 2,625 D
Restricted Stock Units (4) 03/09/2026 M 2,870 (10) (10) Ordinary Shares 2,870 $0 0 D
Stock Options (right to buy) $483.62 03/09/2026 A 25,259 (11) 03/09/2036 Ordinary Shares 25,259 $0 25,259 D
Stock Options (right to buy) $468.77 (12) 03/07/2035 Ordinary Shares 19,156 19,156 D
Stock Options (right to buy) $465.29 (13) 03/07/2034 Ordinary Shares 17,015 17,015 D
Stock Options (right to buy) $354.14 (14) 03/07/2033 Ordinary Shares 18,970 18,970 D
Stock Options (right to buy) $270.99 (15) 03/07/2032 Ordinary Shares 22,535 22,535 D
Stock Options (right to buy) $253.68 (15) 03/08/2031 Ordinary Shares 34,320 34,320 D
Stock Options (right to buy) $173.13 (16) 03/09/2030 Ordinary Shares 43,695 43,695 D
Stock Options (right to buy) $176.63 (17) 03/20/2029 Ordinary Shares 47,020 47,020 D
Stock Options (right to buy) $154 (17) 02/27/2028 Ordinary Shares 64,665 64,665 D
Stock Options (right to buy) $118.71 (17) 02/28/2027 Ordinary Shares 72,795 72,795 D
Deferred Stock Units (4) (18) (18) Ordinary Shares 1,541.952 1,541.952 D
Explanation of Responses:
1. Ordinary shares acquired pursuant to the payout of a performance share unit ("PSU") grant made on March 7, 2023.
2. Ordinary shares withheld from the payout to cover tax withholdings.
3. Ordinary shares acquired pursuant to the payout of a restricted stock unit grant made on March 7, 2023.
4. Conversion to Linde plc Ordinary Shares is on a one-for-one basis.
5. The PSU paid out on March 9, 2026, and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2023-2025 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted on March 7, 2023.
6. The PSU paid out on March 9, 2026, and the number of shares awarded and paid out was determined based upon the relative total shareholder return ("RTSR") of Linde plc from 2023-2025 measured against TSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted on March 7, 2023.
7. Restricted Stock Units that will vest in full and payout on or about March 9, 2029 in Linde plc Ordinary Shares on a one-for-one basis.
8. Restricted Stock Units that will vest in full and payout on or about March 7, 2028 in Linde plc Ordinary Shares on a one-for-one basis.
9. Restricted Stock Units that will vest in full and payout on or about March 7, 2027 in Linde plc Ordinary Shares on a one-for-one basis.
10. Restricted Stock Units that vested in full and paid out on March 9, 2026 in Linde plc Ordinary Shares on a one-for-one basis.
11. This option vests over three years in three consecutive equal annual installments beginning on March 9, 2027.
12. This option vests over three years in three consecutive equal annual installments beginning on March 7, 2026.
13. This option vests over three years in three consecutive equal annual installments beginning on March 7, 2025.
14. This option vests over three years in three consecutive equal annual installments beginning on March 7, 2024.
15. This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023.
16. This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021.
17. This option vested in full and became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.
18. Deferred stock units acquired under the Linde Compensation Deferral Plan ("Plan"). The deferred stock units will payout in Linde plc Ordinary Share on a one-for-one basis in accordance with the Plan.
Remarks:
Anthony M. Pepper as attorney-in-fact 03/11/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Linde (LIN) CFO Matthew J. White report in this Form 4?

Linde CFO Matthew J. White reported equity compensation activity, including new grants of performance share units, restricted stock units, and stock options, plus the payout of earlier awards into ordinary shares. The filing reflects routine compensation and tax withholding rather than open-market buying or selling.

How many Linde ordinary shares did the CFO receive from PSU and RSU payouts?

The CFO received 13,876 Linde ordinary shares from the payout and exercise of performance share units and restricted stock units. These shares came from awards granted in March 2023 that vested based on company performance and time-vesting conditions through 2025 and March 2026.

How many Linde shares were withheld for taxes in this Form 4 filing?

A total of 6,431 Linde ordinary shares were withheld to satisfy tax obligations related to the vesting and payout of equity awards. These tax withholdings are coded as “F” transactions and are not open-market sales, but mandatory share disposals to cover liabilities.

What new stock options did Linde grant to its CFO on March 9, 2026?

Linde granted the CFO stock options over 25,259 ordinary shares at an exercise price of 483.6200 per share, expiring in 2036. According to footnotes, this option vests in three equal annual installments beginning on March 9, 2027, providing long-term incentive alignment.

What are the CFO’s Linde share holdings after these transactions?

After these transactions, the CFO directly holds 83,094.804 Linde ordinary shares. He also has indirect ownership of 3,096.221 ordinary shares through a 401(k) plan and retains multiple unexercised restricted stock units, deferred stock units, and options expiring between 2027 and 2035.

Were any of the Linde CFO’s transactions open-market purchases or sales?

No open-market purchases or sales are reported. The transactions consist of grants of performance share units, restricted stock units, and options, plus exercises of these awards and share withholdings coded “F” to pay taxes. The filing reflects compensation and settlement mechanics, not discretionary trading.
Linde Plc

NASDAQ:LIN

View LIN Stock Overview

LIN Rankings

LIN Latest News

LIN Latest SEC Filings

LIN Stock Data

223.15B
461.44M
Specialty Chemicals
Industrial Inorganic Chemicals
Link
United Kingdom
WOKING SURREY